Researchers from Charité – Universitätsmedizin Berlin and EPFL, Lausanne have succeeded in restoring motor function following spinal cord injury. The researchers were able to show that coordinated muscle movement is the result of alternating activation patterns emanating from the spinal cord. Newly-developed implants, which use electrical stimulation to mimic these signals, were used to…
Studies are underway to determine if a new modular partial wrist replacement will allow for better movement and last longer than traditional implants for people seeking relief from painful wrist arthritis. Although current options such as total wrist replacement and wrist fusion can alleviate pain, patients are often limited in performing certain activities after surgery.
By implanting electrodes in the brain tissue one can stimulate or capture signals from different areas of the brain. These types of brain implants, or neuro-prostheses as they are sometimes called, are used to treat Parkinson's disease and other neurological diseases.
Whether for individual micro-implants or for micro-implants with medicine depots – additive processes are ideally suited for manufacturing such components. In the project “REMEDIS”, scientists at the Laser Zentrum Hannover e.V. (LZH) have established a highly automated laser melting process to produce or coat implants made of platinum, nickel-titanium (NiTi) or stainless steel.
When a patient receives a new hip, it is usually adjusted only approximately to leg length. Greater accuracy requires a more precise measuring process as well as adjustable implants. Now, a new type of measurement method coupled with a modular implant should allow orthopedic surgeons to precisely calibrate leg length after the operation so it matches its original length.
Prosthetic joint infections (PJI) are the most frequent complication in orthopaedic implant patients and may occur any time: weeks, months, or even years after an implantation. Report: Ludger Weß
French authorities have given the green light for continuing the clinical trial for the first fully implantable mechanical heart after a four-month review of the device and the causes of death of the first patient to receive the prosthesis
A cardiac surgeon, Wolfgang Goetz MD once stitched together custom aortic valves in the operating room. Today he is CEO of Transcatheter Technologies in Regensburg.
This summer the world’s first implantations of Biotronik’s new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronisation therapy defibrillators) took place at the Spedali Civili Hospital, Brescia, Italy.
The highly-anticipated and positive results from the IN-TIME study of home monitoring technology were recently presented in a hotline session at this year’s European Society of Cardiology (ESC) congress by coordinating investigator Professor Gerhard Hindricks MD, from the Heart Centre, University of Leipzig, Germany.
In France, every year 15,000 women undergo complete or partial mastectomy due to breast cancer. Only about a third of them, i.e. around 5,000 patients, use the possibilities reconstructive surgery offers and 70 percent of those women opt for an implant although it is associated with a risk of infection because the body might react negatively to the foreign object.
Shaken by two medical implant scandals, France is scrambling to rebuild confidence in its system of medical products and medication surveillance, John Brosky reports
Artificial hearts, originally designed to bridge the time on the waiting list for a heart transplant, in recent years have increasingly become an independent treatment option for patients with chronic heart failure (HF). Interview: Bettina Döbereiner
Cardiology is playing an increasingly important role in today’s healthcare environment and, as a direct result, cardiologists are facing new challenges almost every day. Addressing the need of improving clinician confidence and diagnostic accuracy, Toshiba Medical Systems Europe presented two symposia on the first day of the European Congress of Cardiology, to be held in Munich, Germany, 25-28…
The European medical technology industry association Eucomed notes with great concern recent press reports that the French firm Poly Implant Prothèse (PIP) may have violated the regulations by using unapproved industrial-grade silicone in some of its implantable products and by allegedly falsifying or withholding documents.
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.
